Tag Archives: NYRT

Top Casino Stocks To Watch For 2019

Related LVS 5 Trends U.S. Casino Investors Need To Watch Deutsche Bank Says Buy MGM Following SotP Analysis, 'Encouraging' Q4 Metrics Macau at the crossroads (Seeking Alpha)
Related Benzinga's Top Upgrades Morgan Stanley Revises Triple-Net REIT Ratings Prior To Q2 Earnings

One of the more unique technical analysis metrics used to determine buy and sell signals is Parabolic SAR. Developed by Welles Wilder in 1978, the “SAR” stands for “stop and reverse.”

Top Casino Stocks To Watch For 2019: Globus Medical, Inc.(GMED)

Advisors’ Opinion:

  • [By Logan Wallace]

    Globus Medical Inc (NYSE:GMED) – Research analysts at William Blair cut their Q2 2018 earnings per share (EPS) estimates for shares of Globus Medical in a report released on Thursday, May 3rd. William Blair analyst K. Krum now forecasts that the medical device company will earn $0.35 per share for the quarter, down from their previous estimate of $0.37. William Blair also issued estimates for Globus Medical’s Q3 2018 earnings at $0.35 EPS, FY2018 earnings at $1.52 EPS, Q1 2019 earnings at $0.42 EPS, Q3 2019 earnings at $0.42 EPS, Q4 2019 earnings at $0.46 EPS and FY2019 earnings at $1.71 EPS.

  • [By Joseph Griffin]

    Schwab Charles Investment Management Inc. raised its stake in shares of Globus Medical Inc (NYSE:GMED) by 8.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 421,775 shares of the medical device company’s stock after purchasing an additional 31,253 shares during the period. Schwab Charles Investment Management Inc. owned 0.44% of Globus Medical worth $21,013,000 at the end of the most recent reporting period.

Top Casino Stocks To Watch For 2019: New York REIT, Inc.(NYRT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media coverage about New York REIT (NYSE:NYRT) has been trending somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. New York REIT earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the real estate investment trust an impact score of 46.2668688678986 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Joseph Griffin]

    Media headlines about New York REIT (NYSE:NYRT) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. New York REIT earned a news impact score of 0.17 on Accern’s scale. Accern also gave news coverage about the real estate investment trust an impact score of 46.6379734958041 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Max Byerly]

    New York REIT (NYSE:NYRT) reached a new 52-week high and low on Monday . The stock traded as low as $17.51 and last traded at $17.60, with a volume of 7341 shares traded. The stock had previously closed at $17.85.

Top Casino Stocks To Watch For 2019: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Sean Williams]

    Perhaps no company will be guiltier of drowning its investors in share dilution more than Aurora Cannabis (NASDAQOTH:ACBFF). After finishing fiscal 2014 with just over 16 million shares outstanding, Aurora Cannabis ended the third quarter of fiscal 2018 with almost 565 million shares outstanding. Having recently announced an all-share acquisition of MedReleaffor what amounted to $2.5 billion at the time, Aurora Cannabis could have in excess of 1 billion shares outstanding by this time next year. Aurora would have to earn CA$100 million ($77 million) just to generate $0.10 in annual EPS. That’s insane, and it’s all the more reason to avoid it and a handful of dilution-happy pot stocks.

  • [By Sean Williams]

    For example, Aurora Cannabis (NASDAQOTH:ACBFF) has suggested that it could lead the pack by producing 570,000 kilograms of cannabis-equivalent production yearly, when at full capacity. But when Oct. 17 rolls around, it’s not going to be anywhere near this level. Its 800,000-square-foot Aurora Sky facility will be done by then, and it’s capable of just over 100,000 kilograms of cannabis production annually, but its recently announced Aurora Sun facility in Alberta, and its partnered Aurora Nordic project, won’t be completely online until a later date.

  • [By ]

    What are the risks? First off, the Cannabis market in Canada is already competitive, and it’s the fifth largest company behind the likes of Canopy (OTCPK:TWMJF), Aurora (OTCQX:ACBFF), Aphria (OTCQB:APHQF), Medreleaf (OTCPK:MEDFF), and Cronos (OTC:CRON). What’s more, there are approximately 228 million fully diluted shares, selling at $3.16/share ($4.04/share $CAD), and the company generated $CAD4.09mm in 2017 revenues. That’s quite a premium, and Hydropothecary Corp. trades expensively at a 225x sales multiple. Caveat emptor.

  • [By Sean Williams]

    Over the past year and change, three cannabis growers have maintained their position near the head of the pack in terms of production: Aurora Cannabis (NASDAQOTH:ACBFF), Canopy Growth Corporation, and Aphria. According to company estimates, Aurora Cannabis and Aphria are on track to produce 570,000 kilograms (assuming the completed purchase of MedReleaf (NASDAQOTH:MEDFF)) and 255,000 kilograms of cannabis annually, respectively, with Canopy Growth likely producing around 500,000 kilograms a year, by my best estimate.

  • [By Keith Speights]

    Big Canadian marijuana growers like Canopy Growth (NYSE:CGC), Aurora Cannabis (NASDAQOTH:ACBFF), and Aphria (NASDAQOTH:APHQF) aren’t building a baseball field in hopes that famous dead players will show up. However, they are cranking up production capacity in the hopes that there’ll be a huge demand for recreational marijuana in Canada.

  • [By ]

    As of the time of this writing, the average price to sales ratio of the large Canadian cannabis producers is 40 (Aurora (OTCQX:ACBFF): 33; Canopy (OTCPK:TWMJF): 65; Aphria (OTCQB:APHQF): 28.5; MedReleaf (OTCPK:MEDFF): 35). Given iAnthus’ vertical integration and lack of competition, their margins should be significantly better than any of those firms. However, since they operate in the US where there is greater legal risk, we will reduce that multiple by half. Assuming the low end of expected revenue for 2018 of $20 million, and a P/S of 20, we arrive at a valuation of $400,000,000, giving us a one year price target of $5/share.

Hot Undervalued Stocks To Buy For 2019

Introduction

Several articles appeared in SA noting that Commerzbank AG (OTCPK:CRZBY, the ADR) could be an interesting M&A candidate. We agree with such thesis. The bank is being dramatically undervalued by the market. It is trading at half of its book value per share. In addition, its cash per share is more than ten times its current share price.

Obviously, the political conditions in Europe and the interest rates in the Eurozone are not helping the bank. Additionally, we believe that the EU may not be much interested in seeing mergers between banks. As compared to the US, the financial sector is highly consolidated.

In this article, we will provide all the good and bad reasons for executing a corporate transaction. Furthermore, we will develop several case scenarios. We will also explain how will they affect the share price.

Financial Valuations and Bank Reaction

Before we proceed further, have a look at the most significant financial stats of Commerzbank (source):

Hot Undervalued Stocks To Buy For 2019: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By ]

    Booker’s report took on other companies as well. Pfizer (PFE) , Gilead Sciences (GILD) , AbbVie  (ABBV) , Amgen (AMGN) , Bristol-Myers Squibb (BMY) Eli Lilly & Co. (LLY) , and Mylan NV (MYL) are cited for everything from raising drug prices, to stock buybacks and putting shareholder interest before that of the public.

  • [By Chris Neiger, Anders Bylund, and Todd Campbell]

    To help you track down a few of these companies for your portfolio, we reached out to some Motley Fool contributors for dividend stock ideas. They came back with Uniti Group (NASDAQ:UNIT), AbbVie (NYSE:ABBV), and American Tower (NYSE:AMT). Here’s why.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    So which stocks do our healthcare experts have their eye on right now? We asked these three Motley Fool investors to weigh in, and they pickedAbbVie (NYSE:ABBV),Cardinal Health (NYSE:CAH), and Masimo (NASDAQ:MASI).

  • [By George Budwell]

    After releasing downright worrisome first-quarter results, Gilead Sciences (NASDAQ:GILD) has seen its shares drop by a noteworthy 11.7% in the past few days. The big concern is that Gilead’s ailing hepatitis C franchise has yet to stabilize in the wake of newfound competition from AbbVie’s (NYSE:ABBV)Mavyret.

  • [By Keith Speights]

    AbbVie (NYSE:ABBV) ended 2017 with a bang, posting tremendousfourth-quarter results in January. The company has started 2018 with a bang, too.

    On Thursday, AbbVie announced its Q1 earnings results. Wall Street analysts thought the company would report revenue of $7.6 billion. AbbVie’s actual revenue total was $7.9 billion. Analysts expected adjusted earnings per share (EPS) of $1.79. AbbVie reported adjusted EPS in Q1 of $1.87.

  • [By ]

    In keeping with that philosophy, this week’s recommendation for my Income Trader subscribers was in AbbVie (NYSE: ABBV).

    Revisiting This Reliable Trade Target
    I’ve written about AbbVie a few times before. (So far, we’ve made trades on ABBV three times, and all three trades were winners.) It is one of the world’s largest drug makers (the seventh largest by market cap), known to many for its best-selling drug, Humira, a biologic therapy for autoimmune diseases including rheumatoid arthritis, Crohn’s disease and other inflammatory conditions. This is the best-selling drug in the world, with sales of more than $15 billion a year.

Hot Undervalued Stocks To Buy For 2019: ICON plc(ICLR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Senomyx (NASDAQ: SNMX) and ICON (NASDAQ:ICLR) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Hot Undervalued Stocks To Buy For 2019: Aehr Test Systems(AEHR)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

    Get Aehr Test Systems alerts:

    Critical Comparison: Data I/O (DAIO) & Aehr Test Systems (AEHR) (americanbankingnews.com) Form 4 AEHR TEST SYSTEMS For: May 08 Filed by: HENDRICKSON DAVID S (streetinsider.com) Aehr Test Systems (AEHR) CTO David S. Hendrickson Sells 5,000 Shares (americanbankingnews.com) Teradyne (TER) versus Aehr Test Systems (AEHR) Head to Head Review (americanbankingnews.com) Insider Selling: Aehr Test Systems (AEHR) Insider Sells 20,000 Shares of Stock (americanbankingnews.com)

    AEHR remained flat at $$2.28 during trading hours on Monday. The company had a trading volume of 64,100 shares, compared to its average volume of 136,351. Aehr Test Systems has a 52 week low of $2.26 and a 52 week high of $2.28. The stock has a market cap of $50.06 million, a price-to-earnings ratio of -7.86 and a beta of 0.82. The company has a current ratio of 4.62, a quick ratio of 3.20 and a debt-to-equity ratio of 0.33.

Hot Undervalued Stocks To Buy For 2019: Express Scripts Holding Company(ESRX)

Advisors’ Opinion:

  • [By Cory Renauer]

    Regeneron’s cholesterol-lowering medication Praluent was another drug with multibillion-dollar potential that’s been a huge disappointment in the commercial setting. Trying to launch a treatment with a $14,000-per-year price tag didn’t work, but a more affordable solution is getting attention from the right people. Express Scripts (NASDAQ:ESRX), a pharmacy benefits manager with a national formulary that covers around 25 million Americans, recently agreed to a straightforward reimbursement path in return for drastically lowered pricing. Express Scripts also removed Praluent’s market rival Repatha from its formulary.

  • [By WWW.GURUFOCUS.COM]

    For the details of Jeff Ubben’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben

    These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,

  • [By Cory Renauer]

    Sanofi took the assessment and started engaging end payers to see if any would offer easy reimbursement for a lower net price that reflects ICER’s assessment, and the industry listened. As of July 1, the partners will cut the net price of Praluent in return for straightforward access for around 25 million Americans covered by theExpress Scripts (NASDAQ:ESRX) national formulary. Thepharmacy benefits manager, and will also remove formulary access for its main competitor, Amgen’s (NASDAQ:AMGN) Repatha.

  • [By Alexander Bird]

    Both CVS Health Corp. (NYSE: CVS) and Cigna Corp. (NYSE: CI) sank 5% while Express Scripts Holding Co. (NASDAQ: ESRX), one of the primary providers of pharmacy benefits, dropped 9.7% in response to the disruptive impact the announced partnership could have on the industry. Altogether, the healthcare sector lost a combined $30 billion in market share in the first two hours of trading today.

  • [By Joseph Griffin]

    State of Wisconsin Investment Board boosted its stake in Express Scripts (NASDAQ:ESRX) by 25.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,092,444 shares of the company’s stock after acquiring an additional 218,855 shares during the quarter. State of Wisconsin Investment Board owned 0.19% of Express Scripts worth $75,466,000 as of its most recent filing with the SEC.

  • [By ]

    Larry Robbins and his Glenview Capital Management LLC said he is supportive of health insurance titan Cigna Corp.’s (CI) acquisition of Express Scripts Holdings Co. (ESRX) , the country’s largest benefits management group, in a deal announced in March worth $67 billion.

Hot Undervalued Stocks To Buy For 2019: New York REIT, Inc.(NYRT)

Advisors’ Opinion:

  • [By Max Byerly]

    New York REIT (NYSE:NYRT) reached a new 52-week high and low on Monday . The stock traded as low as $17.51 and last traded at $17.60, with a volume of 7341 shares traded. The stock had previously closed at $17.85.

Top High Tech Stocks To Own For 2018

Salesforce.com Inc. (NYSE: CRM) is expected to release its fiscal second-quarter financial earnings report after the markets close on Tuesday. The consensus estimates from Thomson Reuters call for $0.32 in earnings per share (EPS) and $2.51 billion in revenue. The same period of last year reportedly had EPS of $0.24 and $2.04 billion in revenue.

The company’s previouslyissued guidance for the fiscal second quarter pegged revenue at between $2.51 billion and $2.52 billion, with EPS in the range of $0.31 to $0.32. Current analyst estimates already seem to match that.

In its previous quarter, Salesforce posted a 24% increase in revenues, ultimately pushing its stock to all-time highs. At the same time deferred revenue jumped 26%. At the rate this firm has been performing, it seems that there is nowhere to go but up.

The company has recently been upgraded at several top Wall Street firms and looks to be breaking out. Ahead of the earnings report a few analysts weighed in on Salesforce:

Top High Tech Stocks To Own For 2018: New York REIT, Inc.(NYRT)

Advisors’ Opinion:

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) dropped about 2% Wednesday to post a new 52-week low of $4.95 after closing at $5.05 on Tuesday. The 52-week high is $10.15. Volume was around 4 million, about 40% above the daily average of around 2.9million. The company had no specific news.

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) dropped about 2.9% Wednesday to post a new 52-week low of $8.01after closing Tuesday at $8.25. The 52-week high is $10.15. Volume of around 4.7 million shares traded was more than triple the daily average. The company had no specific news.

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) also matched a 52-week low of $3.90 Monday. The stock’s 52-week high is $10.15. Volume of about 1.7 million was about 20% below the daily average. The company had no specific news. The stock is set to close up about 0.3% today.

Top High Tech Stocks To Own For 2018: Rent-A-Center Inc.(RCII)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc performing better with Best Buy Co Inc (NYSE: BBY) being the big winner whilesmall caps hhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII) haveunderperformed, butare showing signs of improvement:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basically breaking even with Best Buy Co Inc (NYSE: BBY) all over the place (albeit it took off again last year) while small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both underperformed for over three years now:

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basicallyabove break even with Best Buy Co Inc (NYSE: BBY)taking off againwhile small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both been sliding in recent years:

  • [By Lisa Levin]

    Rent-A-Center Inc (NASDAQ: RCII) was down, falling around 26 percent to $9.88. Rent-A-Center reported upbeat quarterly earnings, but the company’s sales missed analysts’ estimates.

Top High Tech Stocks To Own For 2018: International Speedway Corporation(ISCA)

Advisors’ Opinion:

  • [By Monica Gerson]

    International Speedway Corp (NASDAQ: ISCA) is estimated to report its quarterly earnings at $0.41 per share on revenue of $146.09 million.

    Mitcham Industries, Inc. (NASDAQ: MIND) is projected to post a quarterly loss at $0.36 per share on revenue of $10.99 million.

  • [By Monica Gerson]

    International Speedway Corp (NASDAQ: ISCA) is projected to report its quarterly earnings at $0.41 per share on revenue of $146.09 million. International Speedway shares declined 1.65 percent to close at $36.26 yesterday.

Top High Tech Stocks To Own For 2018: Discovery Communications, Inc.(DISCA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Discovery Communications Inc. (NASDAQ: DISCA) announced plans to acquire Scripps Networks Interactive, Inc. (NYSE: SNI) for $14.6 billion.

    Discovery will pay $90 per share in cash and stock to buy Scripps. The transaction is projected to close by early 2018.

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Analysts are expecting Discovery Communications Inc. (NASDAQ: DISCA) to have earned $0.47 per share on revenue of $1.69 billion in the latest quarter. Discovery Communications shares rose 0.17 percent to $29.08 in after-hours trading.
    Analysts expect T-Mobile US Inc (NASDAQ: TMUS) to report

Top 10 Heal Care Stocks To Watch Right Now

Over in DigiTimes, contributor Nebojsa Novakovic recently speculated that gaming-oriented graphics processors based on NVIDIA’s (NASDAQ:NVDA) recently announced Volta architecture could use a type of video memory known as HBM2 (“high bandwidth memory 2”) rather than a more traditional graphics double data rate (GDDR) memory.

HBM2 memory is believed to be more expensive to produce than traditional GDDR-type memory, but the idea is that HBM2 is said to offer power efficiency and physical footprint advantages over GDDR-type memories.

Image source: NVIDIA.

Today, NVIDIA’s GP100 chip — which powers the company’s Tesla P100 datacenter accelerator and its Quadro GP100 professional visualization accelerator — uses HBM2, while the company’s gaming-oriented Pascal products (GP102, GP104, GP106, GP107, GP108) use either GDDR5X (for higher-end products) or GDDR5 (for lower-end products).

Top 10 Heal Care Stocks To Watch Right Now: Black Box Corporation(BBOX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Black Box Corporation (NASDAQ: BBOX) is expected to post its quarterly earnings at $0.26 per share on revenue of $218.41 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Top 10 Heal Care Stocks To Watch Right Now: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped about 5.4% Thursday, to post a new 52-week low of $22.78 after closing at $24.07 on Wednesday. The stock’s 52-week high is $51.93. Volume was about 3 times the daily average of around 1.1 million shares. The company had no specific news, but the troubles at Fitbit may be spilling over.

  • [By Nicholas Rossolillo]

    Wearable devices are quickly becoming mainstream technology, with smartwatches and fitness trackers leading the way. You’d never know that based on the performance of traditional watchmaker Fossil Group (NASDAQ:FOSL) as the company is struggling to adapt to the changing times.

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 21% Wednesday, to post a new 52-week low of $18.10 after closing at $22.87 on Tuesday. The stock’s 52-week high is $51.93. Volume was about 15 times the daily average of around 1.2 million shares. The company reported so-so results last night and Wells Fargo cut its rating on the stock to Underperform this morning.

  • [By WWW.THESTREET.COM]

    Fossil is in deep trouble: As mentioned earlier in the week, Fossil (FOSL) came out with more big plans for the smartwatch market at Basel World. Unfortunately, as TheStreet reported, the company is fighting an uphill battle with Apple and could be in big trouble. 

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, NVIDIA (NASDAQ:NVDA) and Fossil Group(NASDAQ:FOSL) attracted heavy investor interest following their quarterly earnings reports.

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 25% Wednesday to post a new 52-week low of $13.65 after closing at $18.15 on Tuesday. The stock’s 52-week high is $36.87. Volume was more than 5 times the daily average of around 1.9 million shares. The company missed analysts’ expectations bigly this morning.

Top 10 Heal Care Stocks To Watch Right Now: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 5.9% on Wednesday to post a new 52-week low of $21.50 after closing at $22.86 on Tuesday. The stock’s 52-week high is $31.36. Volume of about 31 million was more than 7 times the daily average of 4.5 million. The company had no specific news.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 0.6% on Thursday to post a new 52-week low of $21.41 after closing at $21.53 on Wednesday. The stock’s 52-week high is $31.36. Volume was about a third the daily average of around 6 million shares. The company had no specific news Thursday.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 1.2% on Wednesday to post a new 52-week low of $21.44 after closing at $21.70 on Tuesday. The stock’s 52-week high is $31.36. Volume was about half the daily average of around 2.6 million shares. The company had no specific news Wednesday.

Top 10 Heal Care Stocks To Watch Right Now: Barracuda Networks, Inc.(CUDA)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap security and storage solutions stock Barracuda Networks Inc (NYSE: CUDA) reported fiscal Q2 2018 earnings after the market closed Tuesday that were largely in-line, but shares are falling more than 6% in afterhours/premarket trading. Q2 total revenue grew 7% to $94.3 million as subscription revenue grew 14% to $76.0 million representing 81% of total revenue while appliance revenue was $18.3 million versus $21.0 million. GAAP net income was $1.6 million versus GAAP net income of $2.4 million. The CEO commented:

  • [By Chris Lange]

    Barracuda Networks Inc. (NYSE: CUDA) fiscal first-quarter results are scheduled for Monday. The consensus earnings estimate is $0.18 per share, on $91.15 million in revenue. The shares were last seen at $23.85. The consensus price target is $28.56, and the 52-week trading range is $18.67 to $26.69.

  • [By Jayson Derrick]

    It is unclear which company or companies will benefit from this executive order. But that isn’t stopping investors from placing their bets as most cybersecurity stocks were trading higher during Friday’s trading session; at the same time, the Dow Jones Industrial Average and S&P 500 index were trading in the red.

    Shares of Barracuda Networks Inc (NYSE: CUDA) were trading higher by 2.98 percent at $21.77. Shares of Check Point Software Technologies Ltd. (NASDAQ: CHKP) were trading higher by 1.21 percent at $107.00. Shares of FireEye Inc (NASDAQ: FEYE) were trading higher by 0.70 percent at $14.55. Shares of Palo Alto Networks Inc (NYSE: PANW) were trading higher by 0.62 percent at $115.86.

    Related Links:

  • [By Peter Graham]

    The Q3 2017 earnings report for small cap security and storage solutions stock Barracuda Networks Inc (NYSE: CUDA) is scheduled for after the market closes onMonday (October 9th) with shares rising 9% the last time around on a good earnings report.

Top 10 Heal Care Stocks To Watch Right Now: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By Brian Stoffel]

    Last week, management at Veeva Systems (NYSE:VEEV) reported earnings that investors have become accustomed to. In fact, shareholders have been downright spoiled: both the top and bottom lines came in ahead of expectations; annual sales growth from Veeva’s non-CRM division came in at a blistering 113%.

  • [By Brian Stoffel]

    To say that Veeva Systems (NYSE:VEEV) has performed well as a publicly traded company would be an understatement. While the stock itself is actually down since its post-IPO days, the company’s fundamentals have vastly improved during that time frame.

  • [By Brian Stoffel]

    HR and payroll specialist Paycom Software (NYSE:PAYC), mortgage software provider Ellie Mae (NYSE:ELLI), and cloud computing king for drug companies Veeva Systems (NYSE:VEEV) are the three best software companies you could buy in 2017. They share three key traits that any investor can love: high switching costs, blazing growth rates, and founders or CEOs with lots of skin in the game.

  • [By Peter Graham]

    Mid cap global life sciencescloud-based software solutions stock Veeva Systems Inc (NYSE: VEEV) reported fiscal Q1 2018 earnings after the market closed yesterday with earningsbeating expectations. Total revenuesincreased 32% to$157.9 million as subscription services revenues rose 33% to $127.3 million whilenet incomeincreased 57% to $36.0million. The CEO commented:

Top 10 Heal Care Stocks To Watch Right Now: region(DGLD)

Advisors’ Opinion:

  • [By Jim Robertson]

    The VelocityShares 3x Inverse Gold ETN (NASDAQ: DGLD) seeks to provideshort exposure to three times (3x) the daily performance of theS&P GSCI Gold Index. As with UGLD, DGLD would be doing this viafutures contracts.

Top 10 Heal Care Stocks To Watch Right Now: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ: APOP) shares were also up, gaining 135 percent to $7.79 after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.

  • [By Chris Lange]

    Cellect Biotechnology Ltd. (NASDAQ: APOP) reported that it received a formal notice from the U.S. Patent and Trademark Office (USPTO)regarding its method of treatment for immune related disorders. Basically, the USPTO gave a notice of allowance which broadly means the agency intends to issue a patent approval. The treatment method relates to the engineering of regulatory immune cells with enhanced apoptotic activity used for the treatment or prevention for the unmet needs seen in type 1 diabetes, inflammatory bowel disease, graft versus host disease, and transplant rejection.

Top 10 Heal Care Stocks To Watch Right Now: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 48 percent to $3.35. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

  • [By Lisa Levin]

    Shares of ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) got a boost, shooting up 42 percent to $3.22. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.

Top 10 Heal Care Stocks To Watch Right Now: New York REIT, Inc.(NYRT)

Advisors’ Opinion:

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) dropped about 2.9% Wednesday to post a new 52-week low of $8.01after closing Tuesday at $8.25. The 52-week high is $10.15. Volume of around 4.7 million shares traded was more than triple the daily average. The company had no specific news.

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) dropped about 2% Wednesday to post a new 52-week low of $4.95 after closing at $5.05 on Tuesday. The 52-week high is $10.15. Volume was around 4 million, about 40% above the daily average of around 2.9million. The company had no specific news.

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) also matched a 52-week low of $3.90 Monday. The stock’s 52-week high is $10.15. Volume of about 1.7 million was about 20% below the daily average. The company had no specific news. The stock is set to close up about 0.3% today.

  • [By Paul Ausick]

    New York REIT Inc. (NYSE: NYRT) dropped about 11.8% Thursday to post a new 52-week low of $8.55 after closing at $9.69 on Wednesday. The stock’s 52-week high is $10.15. Volume was nearly 20 times the daily average of around 1.9 million shares. The company, which is in the process of liquidating its assets in New York City, announced quarterly results Wednesday afternoon, including a liquidation value of the portfolio of $9.25 per share.

Top 10 Heal Care Stocks To Watch Right Now: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

Nordic American Tankers, Sandridge Trust Tumble into Monday’s 52-Week Low Club

December 18, 2017: Here are four stocks trading with heavy volume among 46 equities making new 52-week lows in Monday’s session. On the NYSE advancers led decliners by more than 2 to 1 and on the Nasdaq, advancers led decliners by the same margin.

Nordic American Tankers Ltd. (NYSE: NAT) dropped about 4.8% Monday to post a new 52-week low of $2.58 after closing at $2.71 on Friday. Volume was around 2.8 million, more than double the daily average of around 2.3 million. The firm sent shareholders a letter this morning explaining the shipper’s recapitalization program.

Colony NorthStar Inc. (NYSE: CLNS) matched a 52-week low of $11.97 set last Friday. The 52-week high is $16.08. Volume was about 2.5 million, nearly equal to the daily average of around 2.6 million shares. The company had no specific news. Shares are on track to close with a gain of nearly 1%.

New York REIT Inc. (NYSE: NYRT) also matched a 52-week low of $3.90 Monday. The stock’s 52-week high is $10.15. Volume of about 1.7 million was about 20% below the daily average. The company had no specific news. The stock is set to close up about 0.3% today.

Sandridge Mississippian Trust II (NYSE: SDR) dropped about 18% Monday to post a new 52-week low of $0.75 after closing at $0.95 on Friday. The 52-week high is $1.79. Volume was around 1.3 million, more than nine times the daily average of around 160,000. The company had no specific news.

ALSO READ: 20 Fresh Stock Buybacks Could Send $100 Billion Back to Shareholders